Brotherspath Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.81 M
as on 14-12-2024
- Company Age 1 Year 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.20 M
as on 14-12-2024
About Brotherspath Diagnostics
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.81 M.
The company currently has active open charges totaling ₹5.20 M.
Akshay Dubey, Deepanshu Dubey, Gireesh Lodhi, and One other member serve as directors at the Company.
- CIN/LLPIN
U86905MP2023PTC066622
- Company No.
066622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2023
- Date of AGM
31 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Brotherspath Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Dubey  | Director | 10-Jul-2023 | Current |
| Deepanshu Dubey | Director | 10-Jul-2023 | Current |
| Gireesh Lodhi | Director | 10-Jul-2023 | Current |
| Vinita Rai | Director | 23-Apr-2024 | Current |
Financial Performance of Brotherspath Diagnostics.
Enhance accessibility to Brotherspath Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Brotherspath Diagnostics?
Unlock access to Brotherspath Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Legal Pulse Medico Legal Advisors & Consultants Private LimitedActive 10 years 11 monthsAkshay Dubey and Gireesh Lodhi are mutual person
- Combat For Fitness Private LimitedActive 1 year 6 months
Akshay Dubey and Gireesh Lodhi are mutual person
- Dhanwantri Imaging And Diagnostic Centre Private LimitedActive 2 years 11 months
Deepanshu Dubey is a mutual person
Charges (Loans)
₹5.20 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2023 | Bank Of India | ₹5.20 M | Open |
How Many Employees Work at Brotherspath Diagnostics?
Unlock and access historical data on people associated with Brotherspath Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brotherspath Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brotherspath Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.